Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients by Lazzari, Tássia Kirchmann et al.
RESEARCH ARTICLE
Leptin and advanced glycation end products
receptor (RAGE) in tuberculosis patients
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The pathogenesis of consumptive syndrome of tuberculosis (TB) is largely unknown. Leptin
concentrations may be high because of the host’s inflammatory response, contributing to
weight loss in patients with TB. The receptor for advanced glycation end products (RAGE) is
also associated with weight loss in patients with TB and is related to enhanced mortality.
The objective of this study was to evaluate the association between leptin and AGE/RAGE.
Methods
Case-control study. Leptin, AGE (carboxymethyl lysine, CML) and soluble RAGE (sRAGE)
were measured from blood samples by ELISA.
Results
We included in the study 34 patients with TB and 34 controls. We found an inverse correla-
tion between serum leptin levels and sRAGE, only in cases (r = -0.609, p < 0.0001). sRAGE
levels were lower in patients with TB who died as compared with patients who survive
(21.90 ± 4.24 pg/mL vs 66.14 ± 29.49 pg/mL; p = 0.045). Leptin levels were higher in pa-
tients with TB who died as compared with patients who survive (14.11 [7.48–14.11] ng/mL
vs 3.08 [0.54–6.34] ng/mL; p = 0.028).
Conclusions
We identified lower sRAGE levels and higher leptin levels in patients with TB who died as
compared with patients who survive. In addition, an inverse and significant correlation
between serum leptin and sRAGE levels was demonstrated. Future studies, with a larger
sample size and in different settings, including not only hospitalized patients, are needed to
confirm these findings.
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Introduction
Tuberculosis (TB) is an infectious disease with a high worldwide rate of morbidity and mortal-
ity. The consumptive nature of TB is related to anorexia and metabolic alterations, whose path-
ogenesis is largely unknown. Inflammatory cytokines are initially suggested as causative
agents, but there is not enough evidence [1].
In the last decades, leptin emerged as a candidate for mediating metabolic changes related
to the consumptive syndrome of TB. It may be involved in the interaction between immune
response and the nutritional status in TB. Low leptin concentrations due to decreased body fat
may be associated with decrease immunity and worse disease outcome. In addition, leptin con-
centrations may be high because of the host’s inflammatory response, suppressing appetite
and contributing to weight loss in patients with TB [2–6].
The receptor for advanced glycation end products (RAGE) is also associated with weight
loss in patients with TB [7]. AGEs are a diverse group of irreversible products resulting from
glycation between reducing sugars and amino groups in proteins, lipids, and nucleic acids [8,
9]. RAGE is expressed in normal lungs, at low levels, and becomes upregulated during inflam-
mation and infection [10–13]. One study demonstrated that RAGE is higher in patients with
TB than in controls, and is related to enhanced mortality [7].
Both leptin and RAGE are associated with weight loss and worse outcomes, and there are
no previous studies evaluating both in patients with TB. Therefore, the aim of this study was to
evaluate the association between leptin and AGE/RAGE in patients with TB and controls.
Methods
Study design and location
We conducted a prospective case-control study in a tertiary care, university-affiliated hospital
(Hospital de Clı́nicas de Porto Alegre–HCPA), from January 2017 to December 2019, to evalu-
ate the association between leptin and AGE/RAGE in patients with TB and controls. The Eth-
ics Committee at HCPA approved the study number 110580/140044), and all subjects gave
written informed consent to participate. We hypothesize that there is a correlation between
leptin and AGE/RAGE. Patients with TB were recruited at HCPA inpatient’s units, and the
control group consisted of volunteers recruited in the same hospital, matched for sex and age
in a 1:1 matching ratio. The control group consisted of volunteers recruited in the same hospi-
tal, selected among members of the patients’ family (who were accompanying the patients at
the hospital). We decided this because cohabitants are exposed to the same risk factors for
tuberculosis and family members who cohabit with patients with TB were examined to exclude
active TB and to detect latent TB. If family member have active or latent TB, he/she was not
included in the study. The only comorbidity allowed among the controls was HIV, because it
is a comorbidity that is also prevalent among the cases.
Patients and data collection
Patients with TB diagnosis, older than 18 years, who agreed to participate, were included in
the study. Patients with extrapulmonary TB, and those who had been on pulmonary TB treat-
ment for more than 3 days, and patients and controls with diabetes, previous TB and pregnant
women were excluded from the study.
After signing informed written consent enrolled subjects were interviewed using a stan-
dardized questionnaire. Demographic and clinical data were recorded. The results of the main
diagnostic tests performed were also recorded, as well as the outcome of hospitalization (dis-
charge or death). The diagnosis of pulmonary TB was based on consensus criteria [14].
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Sputum smears were stained by Ziehl-Neelsen (ZN) staining technique for the detection of
acid-fast bacilli, and culture was performed using the Ogawa-Kudoh method. Drug sensitivity
testing was performed. All patients and controls were tested for HIV.
Laboratory tests
Blood sample was collected between 8 and 9 AM after an overnight fast, centrifuged and
frozen at -80˚C. Leptin, CML, and RAGE were measured by Elisa, according to the manu-
facturer’s instructions, and the quality control passed (leptin: Linco Research, St. Charles,
MO—EZHL-80SK; CML: OxiSelect N-epsilon-(Carboxymethyl) Lysine [Cell Biolabs Inc,
San Diego, CA]—CELL-STA816; RAGE: Human RAGE Quantikine [R&D Systems Inc.,
Minneapolis, MN]—RAB0007).
Statistical analysis
Data analysis was performed using IBM SPSS Statistics for Windows, version 22.0 (Armonk,
NY, IBM Corp). Data were presented as number of cases, mean ± standard deviation (SD), or
median with interquartile range (IQR). Shapiro-Wilk test was used for testing normality. Cate-
gorical comparisons were carried out by chi-square test (McNemar). Continuous variables
were compared using the paired t-test or Wilcoxon test. Pearson’s (or Spearman’s when indi-
cated) correlations was performed to evaluate for potential relationships. Multivariable logistic
regression analysis was performed to evaluate if the factors statistically significant in univariate
analysis were independently associated with case/control status. The goodness of fit of the mul-
tiple logistic regression model was assessed using the Hosmer-Lemeshow test. Odds ratios
(ORs) and nominal 95% confidence intervals (CIs) were presented. A two-sided p value� 0.05
was considered significant for all analyses. The sample size was calculated based on the
expected correlation between sRAGE and leptin levels of 0.50. Considering a confidence level
of 95% and a power of 80%, we estimated a sample of at least 29 individuals per group.
Results
During the study period, 34 patients with TB and 34 controls met the inclusion criteria and
were included in the analysis (Fig 1). Table 1 shows the comparison between cases and con-
trols. White race was more common among controls than in cases (82.4% vs 52.9%, p = 0.01).
HIV positivity was more frequent in cases as compared with controls (41.2 vs 8.8, p = 0.002),
and was the only comorbidity present in cases and controls. TB cases had a lower BMI than
controls (19.6 ± 3.6 vs 27.0 ± 5.1, p<0.0001). There was no statistically significant difference in
CML, sRAGE and leptin levels between cases and controls.
Table 2 shows the correlations between leptin, CML, and sRAGE. We found an inverse cor-
relation between serum leptin levels and sRAGE, only in cases (r = -0.609, p< 0.0001).
In a multivariable analysis model including white race, HIV positivity, BMI, sRAGE, and
leptin levels, only white race and BMI were independently associated with case status
(Table 3).
Among TB cases, sRAGE, CML and leptin levels were not different between patients who
lost weight and those who did not. sRAGE levels were lower in patients with TB who died as
compared with patients who survive (21.90 ± 4.24 pg/mL vs 66.14 ± 29.49 pg/mL; p = 0.045).
Leptin levels were higher in patients with TB who died as compared with patients who survive
(14.11 [7.48–14.11] ng/mL vs 3.08 [0.54–6.34] ng/mL; p = 0.028). There was no difference in
CML levels between survivors and non-survivors.
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Discussion
In this case-control study, we aimed to evaluate the association between leptin and AGE/RAGE
in patients with TB and controls. We identified lower sRAGE levels in patients with TB who
died as compared with patients who survive. Also, leptin levels were higher among patients with
TB non-survivors than in survivors. In addition, we found an inverse and significant correlation
between serum leptin and sRAGE levels, in TB cases.
Fig 1. Flow chart of patients included in the study.
https://doi.org/10.1371/journal.pone.0254198.g001
Table 1. Comparison between cases and controls.
Variables Cases n = 34 Controls n = 34 p value
Male sex, n (%) 23 (67.6) 23 (67.6) -
Age (years), mean ± SD 36.7 ± 16.3 37.7 ± 15.7 0.786
White race, n (%) 18 (52.9) 28 (82.4) 0.01
Current smoking, n (%) 21 (61.8) 15 (44.1) 0.145
Alcohol abuse, n (%) 13 (38.2) 6 (17.6) 0.059
Drug use, n (%) 13 (38.2) 7 (20.6) 0.110
HIV positive, n (%) 14 (41.2) 3 (8.8) 0.002
BMI (kg/m2), mean ± SD 19.6 ± 3.6 27.0 ± 5.1 <0.0001
Serum CML (μg/μL), median (IQR) 0.06 (0.03–0.10) 0.07 (0.03–0.14) 0.453
sRAGE (pg/mL), mean ± SD 63.5 ± 30.5 57.5 ± 24.0 0.366
Leptin (ng/mL), median (IQR) 3.30 (0.55–6.68) 4.41 (1.81–7.54) 0.105
SD: standard deviation. HIV: human immunodeficiency syndrome. BMI: body mass index. CML: carboxymethyl lysine. IQR: interquartile range. sRAGE: soluble
receptor of advanced glycation end products.
https://doi.org/10.1371/journal.pone.0254198.t001
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RAGE is a receptor that is involved in pulmonary inflammation and infection. It is
expressed at low levels in normal lung and is upregulated during conditions associated with
inflammation, lung damage, and infection [10–13]. In the present study, we found lower
sRAGE levels in patients with TB who died. In a study conducted in murine models, van Zoe-
len et al demonstrated that RAGE deficient mice displayed more body weight loss and
enhanced mortality [15]. In a previous case-controls study [7], lower sRAGE levels were also
associated with mortality.
Leptin is an adipokine initially implicated in the regulation of food intake and body weight
[16]. In TB, due to decreased body fat, leptin concentrations may be low; however, high leptin
levels were also described as a result of the host’s inflammatory response [3–6]. It has also an
important role in the modulation of innate and adaptive immune responses, and the levels of
expression of leptin in serum are increased after acute inflammation [16]. In our study,
patients with TB non-survivors had higher leptin levels as compared with survivors. There are
no previous studies demonstrating this association in patients with TB. However, elevated lep-
tin levels have already been observed in association with mortality from other diseases [17, 18].
In an investigation with older adults, high leptin levels are predictive of cardiovascular mortal-
ity [18]. High leptin levels nearly doubled overall mortality in males [17].
We demonstrated, in patients with TB, an inverse and significant correlation between
serum leptin and sRAGE levels. This association between leptin and RAGE was previously
demonstrated in a type 2 diabetes mouse model. In this study, the authors showed that the lep-
tin activity can inhibit RAGE expression in β-cells [19].
This study has some methodological limitations. First, the investigation was done in a single
center, and the results may thus not apply to other settings. Second, only hospitalized patients
were included in the study, probably more severe TB cases. Last, the small sample size pre-
cluded us to conduct a multivariable analysis of factors associated with mortality in patients
with TB. In addition, white race and lower BMI were more frequent among patients with TB;
although these are characteristics know to be associated with the disease, it would be important
that, in future studies, the cases and controls be paired for these variables as well. In spite of
Table 2. Bivariate correlations with leptin, CML and sRAGE in patients with TB and controls.
Cases Controls
Leptin Leptin
r p Value r p Value
CML 0.265 0.129 -0.057 0.751
sRAGE -0.609 <0.0001 -0.055 0.755
CML: carboxymethyl lysine. sRAGE: soluble receptor of advanced glycation end products.
https://doi.org/10.1371/journal.pone.0254198.t002
Table 3. Multivariable analysis of factors associated with case status.
Characteristic β SE Wald OR (95% CI) p Value
White race 2.618 1.061 6.091 0.073 (0.009–0.583) 0.014
HIV infection -1.335 1.060 1.586 3.800 (0.476–30.345) 0.208
BMI 0.630 0.182 12.001 0.533 (0.373–0.761) 0.001
sRAGE 0.010 0.019 0.269 0.990 (0.953–1.028) 0.604
Leptin -0.087 0.107 0.668 1.091 (0.885–1.345) 0.414
HIV: human immunodeficiency syndrome. BMI: body mass index. sRAGE: soluble receptor of advanced glycation end products.
https://doi.org/10.1371/journal.pone.0254198.t003
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these concerns, the strength of the present study is that it is the first study to demonstrate the
correlation between serum leptin and sRAGE levels in patients with TB, and also the first one
to show higher leptin levels in patients with TB who died. Nevertheless, our study was much
more hypothesis-generating than designed to answer key mechanistic questions on the roles of
RAGE/leptin in tuberculosis and the use of sRAGE/leptin as a reliable prognostic tool in
tuberculosis.
In conclusion, in this study we identified lower sRAGE levels and higher leptin levels in
patients with TB who died as compared with patients who survive. In addition, an inverse and
significant correlation between serum leptin and sRAGE levels was demonstrated. Future stud-
ies, with a larger sample size and in different settings, including not only hospitalized patients,
are needed to confirm these findings.
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